2022
SecMPNN: 3-Party Privacy-Preserving Molecular Structure Properties Inference
ICASSP 2022accepted
Compound screening is a key step in the development of new drugs. Current high-throughput screening methods cannot be widely adopted by laboratories due to their expensive equipment and low efficiency. The booming deep learning in recent years has provided a new answer to this question. The message…